Mcmillan Shakespeare Limited
ASX: MMS
Solid fundamentals, but weakening momentum clouds near-term growth outlook.
(Source: TradingView) 3-Month Performance Profile of MMS on a DTF compared to S&P/ASX 200 (XJO).
McMillan Shakespeare Limited delivered resilient first-half FY26 results, with revenue rising 11.2% to $297.4 million and operating income increasing 4.4% to $210.1 millio
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
